Intelligent Cardiovascular Diagnostic and Treatment Platform

A next-generation pressure-sensing guidewire system that integrates artificial intelligence, real-time monitoring, and personalized medicine to revolutionize cardiovascular disease diagnosis and treatment.

The original pressure-sensing guidewire patent, while innovative, has limitations in its ability to provide real-time data analysis and personalized treatment plans. The new inventive concept addresses these limitations by incorporating AI-driven analytics, wearable devices, and cloud-based data transmission to provide a more comprehensive and proactive approach to cardiovascular care.

The intelligent cardiovascular diagnostic and treatment platform comprises a pressure-sensing guidewire, an AI module, a data transmission module, and a wearable device. The guidewire collects blood pressure data, which is transmitted to the AI module for analysis and generation of a risk profile or customized treatment plan. The wearable device receives and displays the data, enabling real-time monitoring and patient engagement. The system can be expanded to include a network of guidewires, enabling machine learning-based trend analysis and pattern identification.

The new claims introduce a paradigm shift by integrating AI-driven analytics, real-time monitoring, and personalized medicine, which is a significant departure from the original patent's focus on pressure sensing alone. The inventive step lies in the novel combination of these technologies to create a holistic cardiovascular diagnostic and treatment platform.

Alternative embodiments may include the use of different AI algorithms, integration with electronic health records, or the development of specialized guidewires for specific cardiovascular conditions. Variations may also include the incorporation of additional sensors, such as ECG or oxygen saturation sensors, to provide a more comprehensive picture of cardiovascular health.

The intelligent cardiovascular diagnostic and treatment platform has significant commercial potential in the medical device and healthcare industries, particularly in the areas of cardiovascular disease diagnosis, personalized medicine, and remote patient monitoring. The market for this technology is substantial, with potential applications in hospitals, clinics, and remote healthcare settings.